HCV-positive lymphoma after sustained virological response with direct-acting antiviral agents: The game is not over after HCV eradication

J Viral Hepat. 2018 May;25(5):614-615. doi: 10.1111/jvh.12843. Epub 2018 Mar 1.

Authors

E Rodríguez de Santiago¹, K Velázquez Kennedy², M García González^{1

3}, F Gea Rodríguez^{1

3}, L Téllez Villajos^{1

3}, E Tavío Hernández¹, A Albillos^{1

3

4}

Affiliations

¹ Department of Gastroenterology and Hepatology, Hospital Universitario Ramón y Cajal, University of Alcalá, Madrid, Spain.
² Department of Hematology, Hospital Universitario Ramón y Cajal, University of Alcalá, Madrid, Spain.
³ Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain.
⁴ Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Instituto de Salud Carlos III, Madrid, Spain.

PMID: 29239080
DOI: 10.1111/jvh.12843

No abstract available

Publication types

Letter
Comment

MeSH terms

Antiviral Agents
Hepacivirus
Hepatitis C
Hepatitis C, Chronic
Humans
Lymphoma
Ribavirin*
Sustained Virologic Response*
Treatment Outcome

Substances

Antiviral Agents
Ribavirin